BioSpace News Archive

Drug Development

AIM ImmunoTech Announces Authorizations from Competent Authority and Ethics Board in the Netherlands to Begin a Phase 1b/2 Study Evaluating Ampligen

AIM ImmunoTech Inc. today announced the required approvals from the Netherlands for Erasmus Medical Center (“Erasmus MC”) to begin a Phase 1b/2 study under the previously announced external sponsored collaborative clinical research agreement with AstraZeneca and Erasmus MC.

June 27, 2023
·
4 min read
Business

Edesa Biotech Appoints Biotech Deal Veteran to CFO Role

Edesa Biotech, Inc. today announced that the company’s board of directors has appointed Stephen Lemieux, CPA to the role of Chief Financial Officer, effective July 15, 2023.

June 27, 2023
·
5 min read
Genetown

Third Round of Consumer Testing Strongly Validates Rapid Absorption and Effectiveness of Pressure BioSciences UltraShear Processed Nano-THC Oral Spray

Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBIO” or “Company”) today announced results from a third round of consumer focus group testing of a THC Nanoemulsion Oral Spray designed for rapid, direct absorption through the cheeks and under the tongue.

June 27, 2023
·
7 min read
Business

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today announced that it is advancing the research and development of an artificial intelligence (AI) medical device platform in collaboration with technical advisory partner Reified Labs.

June 27, 2023
·
5 min read
Drug Development

Blue Earth Diagnostics Announces Reader Reproducibility Results from Phase 3 LIGHTHOUSE Trial of POSLUMA® (Flotufolastat F 18) Injection in Newly Diagnosed Prostate Cancer

Blue Earth Diagnostics today announced inter- and intra-reader reproducibility results from its Phase 3 LIGHTHOUSE trial of POSLUMA® (flotufolastat F 18) injection (formerly referred to as 18F-rhPSMA-7.3) in newly diagnosed prostate cancer.

June 27, 2023
·
13 min read
Biotech Beach

Ainos Issues Mid-Year Business Update Letter to Shareholders

Ainos, Inc. is pleased to provide a business update letter to shareholders from Ainos’ Chairman of the Board, President, and Chief Executive Officer, Mr. Chun-Hsien Tsai.

June 27, 2023
·
9 min read
Biotech Beach

GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio

GRI Bio, Inc. today provided an update to the progress of its patent portfolio development.

June 27, 2023
·
6 min read
Policy

FDA Roundup: June 27, 2023

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

June 27, 2023
·
3 min read
TRIUMF Innovations and the Centre for Probe Development and Commercialization to Receive up to $35 Million in Funding for their Canadian Medical Isotope Ecosystem

The Canadian Medical Isotope Ecosystem will support the development, production, advancement and distribution of isotopes, and position Canada as an international medical isotope powerhouse

June 27, 2023
·
3 min read
Business

MEI Pharma Responds to Anson and Cable Car

MEI Pharma, Inc. issued the following statement in response to the disclosure made today by Anson Advisors Inc. and Cable Car Capital LLC.

June 27, 2023
·
12 min read